Skip to main content
GutCited

Peppermint Oil 图表

8 来自同行评审研究的图表

全部 Psyllium Husk Bifidobacterium lactis Fructooligosaccharides (FOS) Lactobacillus plantarum Peppermint Oil Pancreatic Enzymes (Pancrelipase) Curcumin Vitamin A Medium-Chain Triglycerides (MCT Oil) Galactooligosaccharides (GOS) Lactobacillus gasseri Aloe Vera (Inner Leaf Gel) Alpha-Galactosidase Vitamin D L-Glutamine Inulin Ginger Lactase Berberine Omega-3 Fatty Acids (EPA/DHA) Bovine Colostrum Zinc Bifidobacterium bifidum Butyrate (Sodium/Calcium Butyrate) Bacillus coagulans Saccharomyces boulardii Lactobacillus acidophilus N-Acetyl Cysteine (NAC) Bifidobacterium longum
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Figure 1
Figure 1

The Canadian Association of Gastroenterology clinical practice guideline provides an evidence-based framework for managing irritable bowel syndrome, covering diagnosis, dietary modifications, pharmacological treatments, and psychological interventions.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable …

The consensus group concluded that while studies suggest benefits with probiotic therapies overall, and with combination
Figure 3

Evidence evaluation for probiotic therapies in IBS suggests overall benefit, particularly with combination probiotic preparations. Strain-specific recommendations remain difficult due to heterogeneity in study designs and products evaluated.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable …

Figure 4
Figure 4

Dietary interventions for IBS include the low-FODMAP diet, which has demonstrated efficacy in reducing bloating, abdominal pain, and altered bowel habits. A dietitian-guided three-phase approach (restriction, reintroduction, personalization) is recommended.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable …

Figure 6
Figure 6

Antispasmodic agents including peppermint oil, pinaverium, and trimebutine receive conditional recommendations for IBS symptom management. Evidence quality varies across specific agents.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable …

Figure 8
Figure 8

Summary recommendations across all therapeutic categories for IBS are presented with corresponding evidence quality ratings and strength of recommendation. The guideline emphasizes shared decision-making with patients.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable …

FIGURE 1 Risk of bias summary of randomised controlled trials examining the effect of biophenol-rich nutraceuticals on gastrointestinal symptoms and related outcomes in adults with inflammatory related gastrointestinal conditions
Figure 1

FIGURE 1 Risk of bias summary of randomised controlled trials examining the effect of biophenol-rich nutraceuticals on gastrointestinal symptoms and related outcomes in adults with inflammatory related gastrointestinal conditions

Efficacy and safety of biophenol-rich nutraceuticals in adults with inflammatory gastrointestinal diseases …

Figure 2
Figure 2

Efficacy and safety of biophenol-rich nutraceuticals in adults with inflammatory gastrointestinal diseases …

Figure 1. Main mechanisms of action of functional foods, herbal medicine, and other nutraceuticals in IBS. Each icon next to the medicinal products indicates which of the five main pathophysiological mechanisms of IBS the product targets.
Figure 1

Figure 1. Main mechanisms of action of functional foods, herbal medicine, and other nutraceuticals in IBS. Each icon next to the medicinal products indicates which of the five main pathophysiological …

Functional Foods and Nutraceuticals in Irritable Bowel Syndrome.